Supernus Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly) Analysis

Supernus Pharmaceuticals, Inc. (SUPN)

47.05 +0.54 (+1.16%) USD | NASDAQ | Dec 12, 10:16

View EPS Diluted from Other Gain/Loss (Quarterly) for SUPN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial